Home
Center for Diabetes Research

2012

An overview of the most important articles in 2012:

  • Ræder H, Molven A, Njølstad PR. [Tailored medicine or narcissomics?]. Tidsskr Nor Laegeforen. 2012 Sep 4;132(16):1844-5. (only in Norwegian)
  • Negahdar M, Aukrust I, Johansson BB, Molnes J, Molven A, Matschinsky FM, Søvik O, Kulkarni RN, Flatmark T, Njølstad PR, Bjørkhaug L. GCK-MODY diabetes associated with protein misfolding, cellular self-association and degradation. Biochim Biophys Acta. 2012, Nov;1822(11):1705-15.
  • Johansson S, Irgens H, Chudasama KK, Molnes J, Aerts J, Roque FS, Jonassen I, Levy S, Lima K, Knappskog PM, Bell GI, Molven A, Njølstad PR. Exome sequencing and genetic testing for MODY. PLoS One. 2012;7(5):e38050.
  • Gonc EN, Ozturk BB, Haldorsen IS, Molnes J, Immervoll H, Raeder H, Molven A, Søvik O, Njølstad PR. HNF1B mutation in a Turkish child with renal and exocrine pancreas insufficiency, diabetes and liver disease. Pediatr Diabetes. 2012 Mar;13(2):e1-5.
  • Søvik O, Aagenaes O, Eide SÅ, Mackay D, Temple IK, Molven A, Njølstad PR. Familial occurrence of neonatal diabetes with duplications in chromosome 6q24: treatment with sulfonylurea and 40-yr follow-up. Pediatr Diabetes. 2012 Mar;13(2):155-62.
  • Moi LL, Flågeng MH, Gjerde J, Madsen A, Røst TH, Gudbrandsen OA, Lien EA, Mellgren G. Steroid receptor coactivators, HER-2 and HER-3 expression is stimulated by tamoxifen treatment in DMBA-induced breast cancer. BMC Cancer. 2012 Jun 15;12:247.
  • Gjerde J, Gandini S, Guerrieri-Gonzaga A, Haugan Moi LL, Aristarco V, Mellgren G, Decensi A, Lien EA. Tissue distribution of 4-hydroxy N-desmethyltamoxifen and tamoxifen-N-oxide. Breast Cancer Res Treat. 2012 Jul;134(2):693-700.
  • Veum VL, Dankel SN, Gjerde J, Nielsen HJ, Solsvik MH, Haugen C, Christensen BJ, Hoang T, Fadnes DJ, Busch C, Våge V, Sagen JV, Mellgren G. The nuclear receptors NUR77, NURR1 and NOR1 in obesity and during fat loss. Int J Obes (Lond). 2012 Sep;36(9):1195-202
  • Borgeraas H, Strand E, Ringdal Pedersen E, Dierkes J, Ueland PM, Seifert R, Wilberg ER, Bohov P, Berge RK, Nilsen DW, Nygård O. Omega-3 Status and the Relationship between Plasma Asymmetric Dimethylarginine and Risk of Myocardial Infarction in Patients with Suspected Coronary Artery Disease. Cardiol Res Pract. 2012;2012:201742.
  • Vigerust NF, Bohov P, Bjørndal B, Seifert R, Nygård O, Svardal A, Glintborg D, Berge RK, Gaster M. Free carnitine and acylcarnitines in obese patients with polycystic ovary syndrome and effects of pioglitazone treatment. Fertil Steril. 2012 Dec;98(6):1620-6.e1.
  • Strand E, Bjorndal B, Nygard O, Burri L, Berge C, Bohov P, Christensen BJ, Berge K, Wergedahl H, Viste A, Berge RK. Long-term treatment with the pan-PPAR agonist tetradecylthioacetic acid or fish oil is associated with increased cardiac content of n-3 fatty acids in rat. Lipids Health Dis. 2012 Jun 27;11:82.